Bio-Techne (TECH) Long-Term Investments (2010 - 2026)

Bio-Techne's Long-Term Investments history runs 15 years deep, the most recent figure standing at $231.0 million for Q1 2026.

• On a quarterly basis, Long-Term Investments rose 1440.19% year-over-year to $231.0 million in Q1 2026; TTM through Mar 2026 was $231.0 million, a 1440.19% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, down 2.62% from the prior year.
• Long-Term Investments slipped to $231.0 million in Q1 2026 per TECH's latest filing, from $235.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $255.9 million in Q2 2023 and bottomed at $15.0 million in Q1 2025.
• The 5-year median for Long-Term Investments is $235.5 million (2025), against an average of $186.8 million.
• Across the five-year window, Long-Term Investments sank 93.95% in 2025 and soared 1440.19% in 2026, its largest moves.
• Year by year, Long-Term Investments stood at $25.0 million in 2022, then jumped by 898.92% to $249.7 million in 2023, then slipped by 3.35% to $241.4 million in 2024, then fell by 2.62% to $235.0 million in 2025, then decreased by 1.71% to $231.0 million in 2026.
• Per Business Quant, the three latest TECH Long-Term Investments figures stand at $231.0 million (Q1 2026), $235.0 million (Q4 2025), and $234.9 million (Q3 2025).